Primary results from CALIBRATE, the Phase 3 registrational clinical trial of encaleret, will be shared in an oral presentation at the 2026 European Congress of Endocrinology (ECE) on May 12, 2026 at ...
20h
BridgeBio Pharma, Inc.: BridgeBio Reports First Quarter 2026 Financial Results and Corporate Updates
U.S. Attruby® net product revenue, with strong prescribing growth and patient persistence driving continued commercial momentumContinued ...
Can't get enough of the candidates' fierce looks? Here are some best beauty moments from the finalists!
Philstar.com on MSN
Historic UAAP golf tilt draws participation from five schools
MANILA, Philippines — Five schools are fine-tuning their rosters and sharpening their games, but what lies ahead is bigger ...
Parker works closely with its customers, which gives it an informational edge over peers, raises the efficiency of its R&D budget, and drives future growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results